Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chem Res Toxicol ; 9(4): 713-21, 1996 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8831815

RESUMO

Methyleugenol is an allylbenzene food flavoring which has been shown to form DNA and protein adducts, and to cause hepatotoxicity and carcinogenicity in rodents. In order to investigate the nature of the protein adducts, specific antisera were raised by immunizing rabbits with conjugates prepared by coupling 1'-acetoxymethyleugenol, or its acidic congener 3,4-dimethoxycinnamic acid, to rabbit serum albumin (RSA). These polyclonal antisera were shown by enzyme linked immunosorbent assay (ELISA) to contain antibodies which recognized the 3,4-dimethoxyphenyl ring portion of methyleugenol. Analysis of livers from rats given methyleugenol i.p. for 5 days, at doses between 10 and 300 mg/kg/day, revealed dose-dependent formation of novel protein adducts which were recognized by the antisera. The adducts were detected by ELISA and by immunoblotting and were concentrated in the microsomal fraction, and were shown in inhibition studies to be derived from methyleugenol. A 44 kDa adduct was the only protein adduct detected in livers of rats given low loses of methyleugenol (10 or 30 mg/kg/day) and was the major adduct detected in rats given high doses of the compound (100 and 300 mg/kg/day). This adduct was solubilized when microsomal fractions were extracted using 0.1 M sodium carbonate, implying that it is a peripheral membrane protein. A pattern of protein adducts which mirrored the in vivo situation was generated when rat hepatocytes were incubated with 1'-hydroxymethyleugenol in vitro, but could not be reproduced in experiments undertaken using liver microsomes or postmitochondrial supernatants. These findings imply that generation of protein adducts in livers of rats given methyleugenol in vivo proceeds via the 1'-hydroxy metabolite and requires crucial cofactors, and/or structural features, which are present in intact hepatocytes but not in broken cell preparations and which remain to be defined.


Assuntos
Eugenol/análogos & derivados , Aromatizantes/química , Aditivos Alimentares/química , Microssomos Hepáticos/química , Albumina Sérica/química , Animais , Relação Dose-Resposta a Droga , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Eugenol/química , Eugenol/imunologia , Eugenol/toxicidade , Aromatizantes/toxicidade , Aditivos Alimentares/toxicidade , Haptenos/química , Haptenos/imunologia , Soros Imunes/imunologia , Immunoblotting , Fígado/química , Fígado/citologia , Fígado/efeitos dos fármacos , Fígado/imunologia , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/imunologia , Proteínas/análise , Coelhos , Ratos , Ratos Endogâmicos F344 , Kit de Reagentes para Diagnóstico , Albumina Sérica/imunologia , Solubilidade , Espectrofotometria Ultravioleta
2.
Nutr Cancer ; 24(3): 289-98, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8610048

RESUMO

It has previously been observed that allyl isothiocyanate, a compound naturally present in the diet, is more cytotoxic toward the human colorectal adenocarcinoma cell line HT29 in its control transformed state than after exposure to sodium butyrate or to dimethylformamide, which slow growth and induce differentiation (detransformation). In the present study, a range of other dietary compounds were assayed for such selective toxicity. These compounds were chosen as constituents of foodstuffs that have been identified from epidemiologic studies as being potentially antitumorigenic and also as having anticarcinogenic activity in experimental models. Benzyl and phenethyl isothiocyanate, benzyl thiocyanate, and quercetin showed decreased toxicity towards HT29 after detransformation of the cells by one or both treatments, whereas no change was observed in the sensitivity to diallyl sulfide or diallyl disulfide. It is proposed that the presence of such selectively toxic compounds in the diet may inhibit the development of tumors by interfering with the growth of preneoplastic lesions while having little effect on normal cells. The cumulative effects of these inhibitions may contribute to the chemopreventive properties of the parent foodstuffs observed in epidemiologic studies.


Assuntos
Adenocarcinoma/patologia , Compostos Alílicos , Anticarcinógenos/farmacologia , Neoplasias Colorretais/patologia , Alimentos , Butiratos/farmacologia , Ácido Butírico , Diferenciação Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Linhagem Celular Transformada , Dimetilformamida/farmacologia , Humanos , Isotiocianatos/farmacologia , Fenótipo , Sulfetos/farmacologia , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...